Precision Medicine Care in ADHD: The Case for Neural Excitation and Inhibition

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that has become increasingly prevalent worldwide. Its core symptoms, including difficulties regulating attention, activity level, and impulses, appear in early childhood and can persist throughout the lifespan. Current...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Brain sciences Ročník 11; číslo 1; s. 91
Hlavní autori: Mamiya, Ping, Arnett, Anne, Stein, Mark
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Switzerland MDPI AG 13.01.2021
MDPI
Predmet:
ISSN:2076-3425, 2076-3425
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that has become increasingly prevalent worldwide. Its core symptoms, including difficulties regulating attention, activity level, and impulses, appear in early childhood and can persist throughout the lifespan. Current pharmacological options targeting catecholamine neurotransmissions have effectively alleviated symptoms in some, but not all affected individuals, leaving clinicians to implement trial-and-error approach to treatment. In this review, we discuss recent experimental evidence from both preclinical and human studies that suggest imbalance of excitation/inhibition (E/I) in the fronto-striatal circuitry during early development may lead to enduring neuroanatomical abnormality of the circuitry, causing persistence of ADHD symptoms in adulthood. We propose a model of precision medicine care that includes E/I balance as a candidate biomarker for ADHD, development of GABA-modulating medications, and use of magnetic resonance spectroscopy and scalp electrophysiology methods to monitor the effects of treatments on shifting E/I balance throughout the lifespan.
AbstractList Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that has become increasingly prevalent worldwide. Its core symptoms, including difficulties regulating attention, activity level, and impulses, appear in early childhood and can persist throughout the lifespan. Current pharmacological options targeting catecholamine neurotransmissions have effectively alleviated symptoms in some, but not all affected individuals, leaving clinicians to implement trial-and-error approach to treatment. In this review, we discuss recent experimental evidence from both preclinical and human studies that suggest imbalance of excitation/inhibition (E/I) in the fronto-striatal circuitry during early development may lead to enduring neuroanatomical abnormality of the circuitry, causing persistence of ADHD symptoms in adulthood. We propose a model of precision medicine care that includes E/I balance as a candidate biomarker for ADHD, development of GABA-modulating medications, and use of magnetic resonance spectroscopy and scalp electrophysiology methods to monitor the effects of treatments on shifting E/I balance throughout the lifespan.
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that has become increasingly prevalent worldwide. Its core symptoms, including difficulties regulating attention, activity level, and impulses, appear in early childhood and can persist throughout the lifespan. Current pharmacological options targeting catecholamine neurotransmissions have effectively alleviated symptoms in some, but not all affected individuals, leaving clinicians to implement trial-and-error approach to treatment. In this review, we discuss recent experimental evidence from both preclinical and human studies that suggest imbalance of excitation/inhibition (E/I) in the fronto-striatal circuitry during early development may lead to enduring neuroanatomical abnormality of the circuitry, causing persistence of ADHD symptoms in adulthood. We propose a model of precision medicine care that includes E/I balance as a candidate biomarker for ADHD, development of GABA-modulating medications, and use of magnetic resonance spectroscopy and scalp electrophysiology methods to monitor the effects of treatments on shifting E/I balance throughout the lifespan.Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that has become increasingly prevalent worldwide. Its core symptoms, including difficulties regulating attention, activity level, and impulses, appear in early childhood and can persist throughout the lifespan. Current pharmacological options targeting catecholamine neurotransmissions have effectively alleviated symptoms in some, but not all affected individuals, leaving clinicians to implement trial-and-error approach to treatment. In this review, we discuss recent experimental evidence from both preclinical and human studies that suggest imbalance of excitation/inhibition (E/I) in the fronto-striatal circuitry during early development may lead to enduring neuroanatomical abnormality of the circuitry, causing persistence of ADHD symptoms in adulthood. We propose a model of precision medicine care that includes E/I balance as a candidate biomarker for ADHD, development of GABA-modulating medications, and use of magnetic resonance spectroscopy and scalp electrophysiology methods to monitor the effects of treatments on shifting E/I balance throughout the lifespan.
Author Stein, Mark
Arnett, Anne
Mamiya, Ping
AuthorAffiliation 2 Department of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA 98195, USA; arnettab@uw.edu (A.B.A.); mark.stein@seattlechildrens.org (M.A.S.)
1 Institute for Learning and Brain Sciences, University of Washington, Seattle, WA 98195, USA
AuthorAffiliation_xml – name: 2 Department of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA 98195, USA; arnettab@uw.edu (A.B.A.); mark.stein@seattlechildrens.org (M.A.S.)
– name: 1 Institute for Learning and Brain Sciences, University of Washington, Seattle, WA 98195, USA
Author_xml – sequence: 1
  givenname: Ping
  surname: Mamiya
  fullname: Mamiya, Ping
– sequence: 2
  givenname: Anne
  orcidid: 0000-0003-1342-0488
  surname: Arnett
  fullname: Arnett, Anne
– sequence: 3
  givenname: Mark
  surname: Stein
  fullname: Stein, Mark
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33450814$$D View this record in MEDLINE/PubMed
BookMark eNp1kk1vEzEQhi1URD_onRNaiQuXwPhr18sBqUoLjVQKh3K2vPa4cbSxi71B8O-72zSojYQv9ozf99HYM8fkIKaIhLyh8IHzFj522YRYbKAUKEBLX5AjBk0944LJgyfnQ3JaygrGpQC4hFfkkHMhQVFxRK5_ZLShhBSrb-iCDRGruclYhVidnV-ef6pullOmYOVTrq5xk01fXfyxYTDD5DLRVYu4DF2YwtfkpTd9wdPH_YT8_HJxM7-cXX3_upifXc2saGGYcc6EaZWw1rfgoTXMA0rnRC08xa7xdcuhBhTAHCI6plqKqpWGCQ_KNvyELLZcl8xK3-WwNvmvTiboh0TKt9rkIdgeNYqOCoOqMawTSGXHHSrpgPkOqDTdyPq8Zd1tujU6i3EY3_gM-vwmhqW-Tb91o5hiDEbA-0dATr82WAa9DsVi35uIaVM0E42SStZ1PUrf7UlXaZPj-FUPqpop4JPq7dOK_pWya9soqLcCm1MpGb3e9WMsMPSagp5GRO-PyGiEPeOO_V_LPdf4vpw
CitedBy_id crossref_primary_10_1007_s00210_022_02236_0
crossref_primary_10_1002_dev_22228
crossref_primary_10_1016_j_clinph_2024_11_014
crossref_primary_10_1186_s11689_025_09614_8
crossref_primary_10_1093_milmed_usad403
crossref_primary_10_1016_j_neuroimage_2023_119925
crossref_primary_10_1016_j_neuropharm_2024_109897
crossref_primary_10_1038_s41583_025_00943_0
crossref_primary_10_1007_s00787_025_02661_5
crossref_primary_10_3389_fnmol_2022_901309
crossref_primary_10_1007_s00228_022_03449_1
crossref_primary_10_1016_j_neuroimage_2023_120302
crossref_primary_10_3390_biomedicines11082273
crossref_primary_10_1038_s41398_024_02859_2
crossref_primary_10_15557_PiPK_2025_0022
crossref_primary_10_3390_e27060572
crossref_primary_10_1523_ENEURO_0578_24_2025
crossref_primary_10_3390_ijms23052894
crossref_primary_10_12998_wjcc_v10_i26_9219
crossref_primary_10_1016_j_clinph_2024_11_001
crossref_primary_10_1038_s41386_022_01505_z
crossref_primary_10_1177_02698811241271972
crossref_primary_10_1016_j_jpsychires_2023_11_014
crossref_primary_10_1016_j_arr_2022_101838
crossref_primary_10_1016_j_dcn_2022_101073
crossref_primary_10_1016_j_chemosphere_2022_136723
crossref_primary_10_1016_j_dcn_2024_101373
crossref_primary_10_1038_s41386_025_02062_x
crossref_primary_10_3390_app14093792
crossref_primary_10_1016_j_dcn_2021_101035
crossref_primary_10_1016_j_neuropharm_2025_110321
crossref_primary_10_1038_s41390_022_02051_6
crossref_primary_10_1001_jamanetworkopen_2022_8884
crossref_primary_10_3390_e23101321
crossref_primary_10_26034_cortica_2022_3131
Cites_doi 10.1016/S0006-3223(02)01401-4
10.1038/s41380-019-0426-0
10.1371/journal.pbio.2003453
10.1038/npp.2015.153
10.1016/j.neuron.2013.05.016
10.1093/cercor/bhl089
10.1038/s41398-019-0469-7
10.1046/j.1528-1157.2001.042suppl.3008.x
10.1523/JNEUROSCI.4242-15.2016
10.3390/cells8020184
10.1016/j.neuron.2019.01.033
10.1016/j.biopsych.2012.05.012
10.1007/s11920-014-0498-0
10.1016/j.biopsych.2013.10.016
10.3390/biom6020016
10.1016/j.euroneuro.2016.02.007
10.1177/1087054713505322
10.3389/fnint.2020.00031
10.1001/archgenpsychiatry.2011.2280
10.1038/srep33661
10.1016/j.nicl.2017.09.026
10.1093/cercor/bht218
10.1073/pnas.0900728106
10.1093/brain/awu137
10.1016/j.braindev.2013.04.013
10.1016/j.neuron.2010.04.020
10.1056/NEJMra1917069
10.1016/j.psychres.2005.09.002
10.1073/pnas.0501703102
10.1016/j.biopsych.2011.01.022
10.1186/s11689-018-9254-9
10.1002/brb3.484
10.1016/S2215-0366(18)30295-5
10.1038/nm.4225
10.1097/WCO.0000000000000542
10.1016/j.nicl.2017.05.016
10.1177/1087054718816164
10.1002/mrm.21383
10.1001/jamapsychiatry.2016.1572
10.1177/1087054712460087
10.1016/j.neubiorev.2019.02.011
10.1016/j.pharmthera.2010.02.008
10.1016/j.cell.2008.05.054
10.1371/journal.pone.0122063
10.1093/acprof:oso/9780195301069.001.0001
10.1016/j.neuroimage.2011.04.010
10.1038/s41583-019-0195-4
10.1038/tp.2017.10
10.7554/eLife.37799
10.1007/s10802-019-00518-5
10.1176/appi.ajp.2011.11020281
10.1016/j.biopsych.2011.04.018
10.1016/S0092-8674(00)81509-3
10.1177/1550059418817966
10.1097/DBP.0000000000000099
10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J
10.1016/j.neurobiolaging.2019.07.010
10.1016/j.neuroscience.2019.07.014
10.1016/j.neubiorev.2018.08.010
10.1038/npp.2016.237
10.1016/j.jpsychires.2006.12.007
10.1016/j.nicl.2017.06.003
10.1038/nrn920
10.3389/fnhum.2014.00268
10.1073/pnas.1115365109
10.1177/1087054719875786
10.1038/s41588-018-0269-7
10.1111/j.1469-7610.2005.01517.x
10.1126/science.6857253
10.1038/s41467-017-02244-2
10.1089/cap.2009.0033
10.1016/j.neuron.2019.11.011
10.1089/cap.2015.0221
10.1016/j.neuroimage.2004.11.031
10.1093/hmg/ddl152
10.1016/j.neubiorev.2018.02.001
10.1038/npp.2017.236
10.1001/jamapsychiatry.2014.3162
10.1176/jnp.16.1.63
10.3389/fpsyt.2018.00564
10.3389/fpsyt.2011.00065
10.1038/tp.2015.79
10.1007/s00213-014-3849-y
10.2147/NDT.S7256
10.1542/peds.2012-2354
10.1007/s007870050083
10.2147/NDT.S56600
10.1073/pnas.89.2.738
10.2174/0929867322666150209152712
10.1016/j.neuroimage.2017.06.078
10.7554/eLife.01936
10.2147/NDT.S65721
10.1177/0883073812440327
10.1016/j.euroneuro.2012.10.014
10.1080/15374416.2017.1417860
10.1111/j.1600-0447.2011.01786.x
10.1080/15374416.2020.1796680
10.1001/jamapsychiatry.2016.0088
10.1016/j.pscychresns.2020.111082
10.1142/S0219635208001897
10.1152/jn.00388.2019
10.3389/fnbeh.2015.00242
10.1001/jamapsychiatry.2013.277
10.1001/archpsyc.62.8.896
10.3389/fnhum.2019.00042
ContentType Journal Article
Copyright 2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021 by the authors. 2021
Copyright_xml – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021 by the authors. 2021
DBID AAYXX
CITATION
NPM
3V.
7TK
7XB
8FE
8FH
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
GNUQQ
GUQSH
HCIFZ
LK8
M2O
M7P
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.3390/brainsci11010091
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest
Natural Science Collection
ProQuest One
ProQuest Central
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
ProQuest Biological Science Collection
Research Library
Biological Science Database
Research Library (Corporate)
Proquest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Publicly Available Content Database
CrossRef
MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2076-3425
ExternalDocumentID oai_doaj_org_article_e4b14ae87a2b4e15b3de85d02fb015ab
PMC7828220
33450814
10_3390_brainsci11010091
Genre Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GrantInformation_xml – fundername: NIMH NIH HHS
  grantid: 5K99MH116064-02
– fundername: Klingenstein Third Generation Foundation
  grantid: 2020 ADHD Fellowship
– fundername: NIMH NIH HHS
  grantid: K99 MH116064
GroupedDBID 53G
5VS
8FE
8FH
8G5
AADQD
AAFWJ
AAYXX
ABDBF
ABUWG
ACUHS
ADBBV
AFFHD
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
CCPQU
CITATION
DWQXO
EBD
ESX
GNUQQ
GROUPED_DOAJ
GUQSH
HCIFZ
HYE
IAO
IHR
ITC
KQ8
LK8
M2O
M48
M7P
MODMG
M~E
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PQGLB
PQQKQ
PROAC
RPM
3V.
NPM
7TK
7XB
8FK
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c490t-3324a984ccf90f09a2f0e5dd464f1eb7f693060e402deeed2891e895a24f08c73
IEDL.DBID DOA
ISICitedReferencesCount 37
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000609838500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2076-3425
IngestDate Tue Oct 14 19:05:15 EDT 2025
Tue Nov 04 01:36:06 EST 2025
Wed Oct 01 13:57:20 EDT 2025
Fri Jul 25 11:56:58 EDT 2025
Thu Jan 02 22:58:47 EST 2025
Tue Nov 18 21:36:12 EST 2025
Sat Nov 29 07:16:23 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords norepinephrine
amphetamine
methylphenidate
dopamine
inhibitory control
executive function
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c490t-3324a984ccf90f09a2f0e5dd464f1eb7f693060e402deeed2891e895a24f08c73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Both authors contributed equally to the manuscript.
ORCID 0000-0003-1342-0488
OpenAccessLink https://doaj.org/article/e4b14ae87a2b4e15b3de85d02fb015ab
PMID 33450814
PQID 2478628036
PQPubID 2032423
ParticipantIDs doaj_primary_oai_doaj_org_article_e4b14ae87a2b4e15b3de85d02fb015ab
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7828220
proquest_miscellaneous_2478585666
proquest_journals_2478628036
pubmed_primary_33450814
crossref_citationtrail_10_3390_brainsci11010091
crossref_primary_10_3390_brainsci11010091
PublicationCentury 2000
PublicationDate 20210113
PublicationDateYYYYMMDD 2021-01-13
PublicationDate_xml – month: 1
  year: 2021
  text: 20210113
  day: 13
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Brain sciences
PublicationTitleAlternate Brain Sci
PublicationYear 2021
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References ref_94
Deco (ref_35) 2011; 57
Lemonnier (ref_105) 2017; 7
Ende (ref_41) 2015; 41
ref_90
Hagerman (ref_107) 2017; 9
Luo (ref_5) 2019; 13
Pertermann (ref_63) 2019; 4
Purkayastha (ref_95) 2015; 22
Zhang (ref_106) 2020; 10
Barbaresi (ref_9) 2014; 35
Robertson (ref_62) 2019; 122
Kohno (ref_22) 2013; 25
Lenartowicz (ref_61) 2014; 16
Curatolo (ref_99) 2014; 36
Samea (ref_83) 2019; 100
Cohen (ref_96) 2013; 28
Gu (ref_32) 2013; 79
ref_24
Bresnahan (ref_76) 2006; 141
ref_21
Arns (ref_60) 2013; 17
Rubia (ref_78) 2014; 76
Sugiyama (ref_33) 2008; 134
Muthukumaraswamy (ref_55) 2009; 106
Courvoisie (ref_37) 2004; 16
Anagnostou (ref_104) 2018; 31
MacMaster (ref_38) 2003; 53
Kessler (ref_91) 2016; 73
(ref_71) 2016; 22
Tritsch (ref_113) 2012; 490
Li (ref_18) 2006; 15
Solanto (ref_10) 2009; 19
Elia (ref_111) 2018; 9
Huang (ref_34) 1999; 98
Cook (ref_17) 1995; 56
Dramsdahl (ref_40) 2011; 2
Schweren (ref_81) 2016; 26
Bouziane (ref_85) 2018; 17
Vincent (ref_51) 1983; 220
Bollmann (ref_39) 2015; 5
Endres (ref_43) 2015; 9
Nakao (ref_88) 2011; 168
Barkley (ref_3) 2018; 23
Saad (ref_86) 2017; 15
Bridi (ref_44) 2020; 105
Demontis (ref_64) 2019; 51
Carpenter (ref_103) 2010; 127
Tran (ref_45) 2019; 82
Arns (ref_73) 2008; 7
Gao (ref_59) 2017; 158
ref_84
Saad (ref_13) 2020; 14
Lahey (ref_11) 2005; 62
Barbaresi (ref_2) 2013; 131
Mattfeld (ref_92) 2014; 137
Frodl (ref_82) 2012; 125
Todd (ref_16) 2005; 46
Schweren (ref_77) 2013; 23
Adler (ref_110) 2012; 72
Hart (ref_80) 2013; 70
Rosch (ref_23) 2018; 10
He (ref_58) 2010; 66
Stoppel (ref_102) 2018; 43
ref_57
Cook (ref_108) 2017; 42
ref_56
Greven (ref_87) 2015; 72
Patel (ref_49) 2005; 102
Xue (ref_50) 2014; 511
ref_54
ref_53
Freund (ref_52) 1992; 89
Yizhar (ref_46) 2011; 477
Leitner (ref_97) 2014; 8
Danielson (ref_25) 2018; 47
Schrantee (ref_19) 2016; 73
Perlov (ref_42) 2007; 41
Rubia (ref_79) 2011; 70
Cortese (ref_6) 2020; 383
Puts (ref_27) 2020; 301
ref_68
Rodriguez (ref_109) 2020; 9
Arnett (ref_7) 2018; 5
Treiman (ref_101) 2001; 42
Kasparek (ref_14) 2015; 19
Solleveld (ref_116) 2017; 15
Goel (ref_28) 2019; 101
Alberdi (ref_29) 2020; 439
Edden (ref_36) 2012; 69
Fair (ref_65) 2012; 109
Gronier (ref_112) 2015; 232
Lou (ref_115) 2016; 6
Chellappa (ref_47) 2016; 6
Ogrim (ref_75) 2014; 10
Peadon (ref_12) 2010; 6
Bush (ref_15) 2011; 69
(ref_69) 2002; 3
Michelini (ref_93) 2019; 9
Gu (ref_31) 2016; 36
Kirkland (ref_72) 2019; 50
Huang (ref_30) 2019; 20
Murias (ref_89) 2006; 17
Mescher (ref_66) 1998; 11
Tritsch (ref_114) 2014; 3
Clark (ref_100) 1999; 8
Hagerman (ref_98) 2018; 9
Sikirica (ref_8) 2014; 10
Zhao (ref_4) 2019; 47
Lou (ref_20) 2005; 25
Sudre (ref_1) 2018; 94
Edden (ref_67) 2007; 58
Faraone (ref_26) 2018; 87
ref_48
Sohal (ref_70) 2019; 24
Battel (ref_74) 2016; 26
References_xml – volume: 53
  start-page: 184
  year: 2003
  ident: ref_38
  article-title: Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder
  publication-title: Biol. Psychiatry
  doi: 10.1016/S0006-3223(02)01401-4
– volume: 24
  start-page: 1248
  year: 2019
  ident: ref_70
  article-title: Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders
  publication-title: Mol. Psychiatry
  doi: 10.1038/s41380-019-0426-0
– volume: 477
  start-page: 171
  year: 2011
  ident: ref_46
  article-title: Neocortical excitation/inhibition balance in information processing and social dysfunction
  publication-title: Nat. Cell Biol.
– ident: ref_68
– ident: ref_94
  doi: 10.1371/journal.pbio.2003453
– volume: 41
  start-page: 410
  year: 2015
  ident: ref_41
  article-title: Impulsivity and Aggression in Female BPD and ADHD Patients: Association with ACC Glutamate and GABA Concentrations
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2015.153
– volume: 79
  start-page: 335
  year: 2013
  ident: ref_32
  article-title: Obligatory Role for the Immediate Early Gene NARP in Critical Period Plasticity
  publication-title: Neuron
  doi: 10.1016/j.neuron.2013.05.016
– volume: 17
  start-page: 1788
  year: 2006
  ident: ref_89
  article-title: Functional Connectivity of Frontal Cortex in Healthy and ADHD Children Reflected in EEG Coherence
  publication-title: Cereb. Cortex
  doi: 10.1093/cercor/bhl089
– volume: 9
  start-page: 137
  year: 2019
  ident: ref_93
  article-title: Atypical functional connectivity in adolescents and adults with persistent and remitted ADHD during a cognitive control task
  publication-title: Transl. Psychiatry
  doi: 10.1038/s41398-019-0469-7
– volume: 42
  start-page: 8
  year: 2001
  ident: ref_101
  article-title: GABAergic Mechanisms in Epilepsy
  publication-title: Epilepsia
  doi: 10.1046/j.1528-1157.2001.042suppl.3008.x
– volume: 36
  start-page: 10285
  year: 2016
  ident: ref_31
  article-title: Neuregulin-Dependent Regulation of Fast-Spiking Interneuron Excitability Controls the Timing of the Critical Period
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.4242-15.2016
– volume: 490
  start-page: 262
  year: 2012
  ident: ref_113
  article-title: Dopaminergic neurons inhibit striatal output through non-canonical release of GABA
  publication-title: Nat. Cell Biol.
– ident: ref_53
  doi: 10.3390/cells8020184
– volume: 101
  start-page: 543
  year: 2019
  ident: ref_28
  article-title: Autism in the Balance: Elevated E-I Ratio as a Homeostatic Stabilization of Synaptic Drive
  publication-title: Neuron
  doi: 10.1016/j.neuron.2019.01.033
– volume: 9
  start-page: 1
  year: 2017
  ident: ref_107
  article-title: Arbaclofen in fragile X syndrome: Results of phase 3 trials
  publication-title: J. Neurodev. Disord.
– volume: 72
  start-page: 971
  year: 2012
  ident: ref_110
  article-title: A Translational Approach to Evaluate the Efficacy and Safety of the Novel AMPA Receptor Positive Allosteric Modulator Org 26576 in Adult Attention-Deficit/Hyperactivity Disorder
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2012.05.012
– volume: 16
  start-page: 1
  year: 2014
  ident: ref_61
  article-title: Use of EEG to Diagnose ADHD
  publication-title: Curr. Psychiatry Rep.
  doi: 10.1007/s11920-014-0498-0
– volume: 76
  start-page: 616
  year: 2014
  ident: ref_78
  article-title: Effects of Stimulants on Brain Function in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2013.10.016
– ident: ref_48
  doi: 10.3390/biom6020016
– volume: 26
  start-page: 674
  year: 2016
  ident: ref_81
  article-title: Stimulant treatment history predicts frontal-striatal structural connectivity in adolescents with attention-deficit/hyperactivity disorder
  publication-title: Eur. Neuropsychopharmacol.
  doi: 10.1016/j.euroneuro.2016.02.007
– volume: 19
  start-page: 931
  year: 2015
  ident: ref_14
  article-title: Neurobiology of ADHD from childhood to adulthood: Findings of imaging methods
  publication-title: J. Atten. Disord.
  doi: 10.1177/1087054713505322
– volume: 14
  start-page: 31
  year: 2020
  ident: ref_13
  article-title: A Systematic Review of Imaging Studies in the Combined and Inattentive Subtypes of Attention Deficit Hyperactivity Disorder
  publication-title: Front. Integr. Neurosci.
  doi: 10.3389/fnint.2020.00031
– volume: 69
  start-page: 750
  year: 2012
  ident: ref_36
  article-title: Reduced GABA Concentration in Attention-Deficit/Hyperactivity Disorder
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archgenpsychiatry.2011.2280
– volume: 6
  start-page: 33661
  year: 2016
  ident: ref_47
  article-title: Circadian dynamics in measures of cortical excitation and inhibition balance
  publication-title: Sci. Rep.
  doi: 10.1038/srep33661
– volume: 17
  start-page: 53
  year: 2018
  ident: ref_85
  article-title: ADHD and maturation of brain white matter: A DTI study in medication naive children and adults
  publication-title: NeuroImage: Clin.
  doi: 10.1016/j.nicl.2017.09.026
– volume: 25
  start-page: 236
  year: 2013
  ident: ref_22
  article-title: Risk-Taking Behavior: Dopamine D2/D3 Receptors, Feedback, and Frontolimbic Activity
  publication-title: Cereb. Cortex
  doi: 10.1093/cercor/bht218
– volume: 106
  start-page: 8356
  year: 2009
  ident: ref_55
  article-title: Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in response to visual stimulation in humans
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0900728106
– volume: 511
  start-page: 596
  year: 2014
  ident: ref_50
  article-title: Equalizing excitation–inhibition ratios across visual cortical neurons
  publication-title: Nat. Cell Biol.
– volume: 137
  start-page: 2423
  year: 2014
  ident: ref_92
  article-title: Brain differences between persistent and remitted attention deficit hyperactivity disorder
  publication-title: Brain
  doi: 10.1093/brain/awu137
– volume: 36
  start-page: 185
  year: 2014
  ident: ref_99
  article-title: Epilepsy associated with autism and attention deficit hyperactivity disorder: Is there a genetic link?
  publication-title: Brain Dev.
  doi: 10.1016/j.braindev.2013.04.013
– volume: 66
  start-page: 353
  year: 2010
  ident: ref_58
  article-title: The Temporal Structures and Functional Significance of Scale-free Brain Activity
  publication-title: Neuron
  doi: 10.1016/j.neuron.2010.04.020
– volume: 383
  start-page: 1050
  year: 2020
  ident: ref_6
  article-title: Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder
  publication-title: New Engl. J. Med.
  doi: 10.1056/NEJMra1917069
– volume: 141
  start-page: 151
  year: 2006
  ident: ref_76
  article-title: Quantitative EEG analysis in dexamphetamine-responsive adults with attention-deficit/hyperactivity disorder
  publication-title: Psychiatry Res.
  doi: 10.1016/j.psychres.2005.09.002
– volume: 102
  start-page: 5588
  year: 2005
  ident: ref_49
  article-title: The contribution of GABA to glutamate/glutamine cycling and energy metabolism in the rat cortex in vivo
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0501703102
– volume: 69
  start-page: 1160
  year: 2011
  ident: ref_15
  article-title: Cingulate, Frontal, and Parietal Cortical Dysfunction in Attention-Deficit/Hyperactivity Disorder
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2011.01.022
– volume: 10
  start-page: 1
  year: 2020
  ident: ref_106
  article-title: Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios
  publication-title: Transl. Psychiatry
– volume: 10
  start-page: 34
  year: 2018
  ident: ref_23
  article-title: ADHD-related sex differences in fronto-subcortical intrinsic functional connectivity and associations with delay discounting
  publication-title: J. Neurodev. Disord.
  doi: 10.1186/s11689-018-9254-9
– volume: 6
  start-page: e00484
  year: 2016
  ident: ref_115
  article-title: Exogenous dopamine reduces GABA receptor availability in the human brain
  publication-title: Brain Behav.
  doi: 10.1002/brb3.484
– volume: 5
  start-page: 691
  year: 2018
  ident: ref_7
  article-title: Refining treatment choices for ADHD
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(18)30295-5
– volume: 22
  start-page: 1229
  year: 2016
  ident: ref_71
  article-title: Developmental timing and critical windows for the treatment of psychiatric disorders
  publication-title: Nat. Med.
  doi: 10.1038/nm.4225
– volume: 31
  start-page: 119
  year: 2018
  ident: ref_104
  article-title: Clinical trials in autism spectrum disorder: Evidence, challenges and future directions
  publication-title: Curr. Opin. Neurol.
  doi: 10.1097/WCO.0000000000000542
– volume: 15
  start-page: 383
  year: 2017
  ident: ref_86
  article-title: Regional brain network organization distinguishes the combined and inattentive subtypes of Attention Deficit Hyperactivity Disorder
  publication-title: NeuroImage Clin.
  doi: 10.1016/j.nicl.2017.05.016
– volume: 23
  start-page: 907
  year: 2018
  ident: ref_3
  article-title: Hyperactive Child Syndrome and Estimated Life Expectancy at Young Adult Follow-Up: The Role of ADHD Persistence and Other Potential Predictors
  publication-title: J. Atten. Disord.
  doi: 10.1177/1087054718816164
– volume: 58
  start-page: 1276
  year: 2007
  ident: ref_67
  article-title: Spatial effects in the detection of γ-aminobutyric acid: Improved sensitivity at high fields using inner volume saturation
  publication-title: Magn. Reson. Med.
  doi: 10.1002/mrm.21383
– volume: 73
  start-page: 955
  year: 2016
  ident: ref_19
  article-title: Age-dependent effects of methylphenidate on the human dopaminergic system in young vs adult patients with attention-deficit/hyperactivity disorder: A randomized clinical trial
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2016.1572
– volume: 17
  start-page: 374
  year: 2013
  ident: ref_60
  article-title: A decade of EEG theta/beta ratio research in ADHD: A meta-analysis
  publication-title: J. Atten. Disord.
  doi: 10.1177/1087054712460087
– volume: 100
  start-page: 1
  year: 2019
  ident: ref_83
  article-title: Brain alterations in children/adolescents with ADHD revisited: A neuroimaging meta-analysis of 96 structural and functional studies
  publication-title: Neurosci. Biobehav. Rev.
  doi: 10.1016/j.neubiorev.2019.02.011
– volume: 127
  start-page: 78
  year: 2010
  ident: ref_103
  article-title: Mechanism-based approaches to treating fragile X
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2010.02.008
– volume: 134
  start-page: 508
  year: 2008
  ident: ref_33
  article-title: Experience-Dependent Transfer of Otx2 Homeoprotein into the Visual Cortex Activates Postnatal Plasticity
  publication-title: Cell
  doi: 10.1016/j.cell.2008.05.054
– ident: ref_24
  doi: 10.1371/journal.pone.0122063
– ident: ref_57
  doi: 10.1093/acprof:oso/9780195301069.001.0001
– volume: 57
  start-page: 130
  year: 2011
  ident: ref_35
  article-title: Role of local network oscillations in resting-state functional connectivity
  publication-title: NeuroImage
  doi: 10.1016/j.neuroimage.2011.04.010
– volume: 20
  start-page: 563
  year: 2019
  ident: ref_30
  article-title: The diversity of GABAergic neurons and neural communication elements
  publication-title: Nat. Rev. Neurosci.
  doi: 10.1038/s41583-019-0195-4
– volume: 7
  start-page: e1056
  year: 2017
  ident: ref_105
  article-title: Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
  publication-title: Transl. Psychiatry
  doi: 10.1038/tp.2017.10
– ident: ref_56
  doi: 10.7554/eLife.37799
– volume: 47
  start-page: 1327
  year: 2019
  ident: ref_4
  article-title: Family Burden of Raising a Child with ADHD
  publication-title: J. Abnorm. Child Psychol.
  doi: 10.1007/s10802-019-00518-5
– volume: 168
  start-page: 1154
  year: 2011
  ident: ref_88
  article-title: Gray Matter Volume Abnormalities in ADHD: Voxel-Based Meta-Analysis Exploring the Effects of Age and Stimulant Medication
  publication-title: Am. J. Psychiatry
  doi: 10.1176/appi.ajp.2011.11020281
– volume: 70
  start-page: 255
  year: 2011
  ident: ref_79
  article-title: Methylphenidate Normalizes Frontocingulate Underactivation During Error Processing in Attention-Deficit/Hyperactivity Disorder
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2011.04.018
– ident: ref_84
– volume: 98
  start-page: 739
  year: 1999
  ident: ref_34
  article-title: BDNF Regulates the Maturation of Inhibition and the Critical Period of Plasticity in Mouse Visual Cortex
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)81509-3
– volume: 9
  start-page: 212601
  year: 2020
  ident: ref_109
  article-title: Efficacy and safety of a GABAergic drug (Gamalate® B6): Effects on behavior and cognition in young adults with borderline-to-mild intellectual developmental disabilities and ADHD
  publication-title: Drugs Context
– volume: 50
  start-page: 256
  year: 2019
  ident: ref_72
  article-title: Measuring Treatment Response in Pharmacological and Lifestyle Interventions Using Electroencephalography in ADHD: A Review
  publication-title: Clin. EEG Neurosci.
  doi: 10.1177/1550059418817966
– volume: 35
  start-page: 448
  year: 2014
  ident: ref_9
  article-title: Long-Term Stimulant Medication Treatment of Attention-Deficit/Hyperactivity Disorder
  publication-title: J. Dev. Behav. Pediatr.
  doi: 10.1097/DBP.0000000000000099
– volume: 11
  start-page: 266
  year: 1998
  ident: ref_66
  article-title: Simultaneous in vivo spectral editing and water suppression
  publication-title: NMR Biomed.
  doi: 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J
– volume: 82
  start-page: 120
  year: 2019
  ident: ref_45
  article-title: Reduced cognitive performance in aged rats correlates with increased excitation/inhibition ratio in the dentate gyrus in response to lateral entorhinal input
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2019.07.010
– volume: 439
  start-page: 163
  year: 2020
  ident: ref_29
  article-title: Oligodendrocyte Differentiation and Myelination Is Potentiated via GABAB Receptor Activation
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2019.07.014
– volume: 56
  start-page: 993
  year: 1995
  ident: ref_17
  article-title: Association of attention-deficit disorder and the dopamine transporter gene
  publication-title: Am. J. Hum. Genet.
– volume: 94
  start-page: 198
  year: 2018
  ident: ref_1
  article-title: Growing out of attention deficit hyperactivity disorder: Insights from the ‘remitted’brain
  publication-title: Neurosci. Biobehav. Rev.
  doi: 10.1016/j.neubiorev.2018.08.010
– volume: 42
  start-page: 1390
  year: 2017
  ident: ref_108
  article-title: Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2016.237
– volume: 41
  start-page: 934
  year: 2007
  ident: ref_42
  article-title: Reduced cingulate glutamate/glutamine-to-creatine ratios in adult patients with attention deficit/hyperactivity disorder – A magnet resonance spectroscopy study
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2006.12.007
– volume: 15
  start-page: 812
  year: 2017
  ident: ref_116
  article-title: Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients
  publication-title: NeuroImage Clin.
  doi: 10.1016/j.nicl.2017.06.003
– volume: 3
  start-page: 728
  year: 2002
  ident: ref_69
  article-title: Excitatory actions of gaba during development: The nature of the nurture
  publication-title: Nat. Rev. Neurosci.
  doi: 10.1038/nrn920
– volume: 8
  start-page: 268
  year: 2014
  ident: ref_97
  article-title: The co-occurrence of autism and attention deficit hyperactivity disorder in children—What do we know?
  publication-title: Front. Hum. Neurosci.
  doi: 10.3389/fnhum.2014.00268
– volume: 109
  start-page: 6769
  year: 2012
  ident: ref_65
  article-title: Distinct neuropsychological subgroups in typically developing youth inform heterogeneity in children with ADHD
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1115365109
– ident: ref_21
  doi: 10.1177/1087054719875786
– volume: 51
  start-page: 63
  year: 2019
  ident: ref_64
  article-title: Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
  publication-title: Nat. Genet.
  doi: 10.1038/s41588-018-0269-7
– volume: 46
  start-page: 1067
  year: 2005
  ident: ref_16
  article-title: Collaborative analysis of DRD4 and DAT genotypes in population-defined ADHD subtypes
  publication-title: J. Child Psychol. Psychiatry
  doi: 10.1111/j.1469-7610.2005.01517.x
– volume: 220
  start-page: 1309
  year: 1983
  ident: ref_51
  article-title: Hypothalamic gamma-aminobutyric acid neurons project to the neocortex
  publication-title: Science
  doi: 10.1126/science.6857253
– volume: 9
  start-page: 1
  year: 2018
  ident: ref_111
  article-title: Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-017-02244-2
– volume: 19
  start-page: 663
  year: 2009
  ident: ref_10
  article-title: Stimulant Drug Response in the Predominantly Inattentive and Combined Subtypes of Attention-Deficit/Hyperactivity Disorder
  publication-title: J. Child Adolesc. Psychopharmacol.
  doi: 10.1089/cap.2009.0033
– volume: 105
  start-page: 621
  year: 2020
  ident: ref_44
  article-title: Daily Oscillation of the Excitation-Inhibition Balance in Visual Cortical Circuits
  publication-title: Neuron
  doi: 10.1016/j.neuron.2019.11.011
– volume: 26
  start-page: 555
  year: 2016
  ident: ref_74
  article-title: Intrinsic Brain Connectivity Following Long-Term Treatment with Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder
  publication-title: J. Child Adolesc. Psychopharmacol.
  doi: 10.1089/cap.2015.0221
– volume: 25
  start-page: 868
  year: 2005
  ident: ref_20
  article-title: Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder
  publication-title: NeuroImage
  doi: 10.1016/j.neuroimage.2004.11.031
– volume: 15
  start-page: 2276
  year: 2006
  ident: ref_18
  article-title: Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD)
  publication-title: Hum. Mol. Genet.
  doi: 10.1093/hmg/ddl152
– volume: 87
  start-page: 255
  year: 2018
  ident: ref_26
  article-title: The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities
  publication-title: Neurosci. Biobehav. Rev.
  doi: 10.1016/j.neubiorev.2018.02.001
– volume: 43
  start-page: 513
  year: 2018
  ident: ref_102
  article-title: R-Baclofen Reverses Cognitive Deficits and Improves Social Interactions in Two Lines of 16p11.2 Deletion Mice
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2017.236
– volume: 72
  start-page: 490
  year: 2015
  ident: ref_87
  article-title: Developmentally Stable Whole-Brain Volume Reductions and Developmentally Sensitive Caudate and Putamen Volume Alterations in Those with Attention-Deficit/Hyperactivity Disorder and Their Unaffected Siblings
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2014.3162
– volume: 16
  start-page: 63
  year: 2004
  ident: ref_37
  article-title: Neurometabolic Functioning and Neuropsychological Correlates in Children With ADHD-H: Preliminary Findings
  publication-title: J. Neuropsychiatry Clin. Neurosci.
  doi: 10.1176/jnp.16.1.63
– volume: 9
  start-page: 564
  year: 2018
  ident: ref_98
  article-title: Fragile X-Associated Neuropsychiatric Disorders (FXAND)
  publication-title: Front. Psychiatry
  doi: 10.3389/fpsyt.2018.00564
– volume: 2
  start-page: 65
  year: 2011
  ident: ref_40
  article-title: Adults with Attention-Deficit/Hyperactivity Disorder? A Brain Magnetic Resonance Spectroscopy Study
  publication-title: Front. Psychiatry
  doi: 10.3389/fpsyt.2011.00065
– volume: 5
  start-page: e589
  year: 2015
  ident: ref_39
  article-title: Developmental changes in gamma-aminobutyric acid levels in attention-deficit/hyperactivity disorder
  publication-title: Transl. Psychiatry
  doi: 10.1038/tp.2015.79
– volume: 4
  start-page: 743
  year: 2019
  ident: ref_63
  article-title: The Modulation of Neural Noise Underlies the Effectiveness of Methylphenidate Treatment in Attention-Deficit/Hyperactivity Disorder
  publication-title: Biol. Psychiatry Cogn. Neurosci. Neuroimaging
– volume: 232
  start-page: 2191
  year: 2015
  ident: ref_112
  article-title: Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-014-3849-y
– volume: 6
  start-page: 509
  year: 2010
  ident: ref_12
  article-title: Distinguishing between attention-deficit hyperactivity and fetal alcohol spectrum disorders in children: Clinical guidelines
  publication-title: Neuropsychiatr. Dis. Treat.
  doi: 10.2147/NDT.S7256
– volume: 131
  start-page: 637
  year: 2013
  ident: ref_2
  article-title: Mortality, ADHD, and Psychosocial Adversity in Adults with Childhood ADHD: A Prospective Study
  publication-title: Pediatrics
  doi: 10.1542/peds.2012-2354
– volume: 8
  start-page: 50
  year: 1999
  ident: ref_100
  article-title: Autistic symptoms in children with attention deficit-hyperactivity disorder
  publication-title: Eur. Child Adolesc. Psychiatry
  doi: 10.1007/s007870050083
– volume: 10
  start-page: 231
  year: 2014
  ident: ref_75
  article-title: Predicting the clinical outcome of stimulant medication in pediatric attention-deficit/hyperactivity disorder: Data from quantitative electroencephalography, event-related potentials, and a go/no-go test
  publication-title: Neuropsychiatr. Dis. Treat.
  doi: 10.2147/NDT.S56600
– volume: 89
  start-page: 738
  year: 1992
  ident: ref_52
  article-title: gamma-Aminobutyric acid-containing basal forebrain neurons innervate inhibitory interneurons in the neocortex
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.89.2.738
– volume: 22
  start-page: 1850
  year: 2015
  ident: ref_95
  article-title: A Review on GABA/Glutamate Pathway for Therapeutic Intervention of ASD and ADHD
  publication-title: Curr. Med. Chem.
  doi: 10.2174/0929867322666150209152712
– ident: ref_54
– volume: 158
  start-page: 70
  year: 2017
  ident: ref_59
  article-title: Inferring synaptic excitation/inhibition balance from field potentials
  publication-title: NeuroImage
  doi: 10.1016/j.neuroimage.2017.06.078
– volume: 3
  start-page: e01936
  year: 2014
  ident: ref_114
  article-title: Midbrain dopamine neurons sustain inhibitory transmission using plasma membrane uptake of GABA, not synthesis
  publication-title: eLife
  doi: 10.7554/eLife.01936
– volume: 10
  start-page: 1543
  year: 2014
  ident: ref_8
  article-title: Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review
  publication-title: Neuropsychiatr. Dis. Treat.
  doi: 10.2147/NDT.S65721
– volume: 28
  start-page: 120
  year: 2013
  ident: ref_96
  article-title: Prevalence of epilepsy and attention-deficit hyperactivity (ADHD) disorder: A population-based study
  publication-title: J. Child Neurol.
  doi: 10.1177/0883073812440327
– volume: 23
  start-page: 1151
  year: 2013
  ident: ref_77
  article-title: MR imaging of the effects of methylphenidate on brain structure and function in Attention-Deficit/Hyperactivity Disorder
  publication-title: Eur. Neuropsychopharmacol.
  doi: 10.1016/j.euroneuro.2012.10.014
– volume: 47
  start-page: 199
  year: 2018
  ident: ref_25
  article-title: Prevalence of Parent-Reported ADHD Diagnosis and Associated Treatment Among U.S. Children and Adolescents, 2016
  publication-title: J. Clin. Child Adolesc. Psychol.
  doi: 10.1080/15374416.2017.1417860
– volume: 125
  start-page: 114
  year: 2012
  ident: ref_82
  article-title: Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects
  publication-title: Acta Psychiatr. Scand.
  doi: 10.1111/j.1600-0447.2011.01786.x
– ident: ref_90
  doi: 10.1080/15374416.2020.1796680
– volume: 73
  start-page: 481
  year: 2016
  ident: ref_91
  article-title: Growth Charting of Brain Connectivity Networks and the Identification of Attention Impairment in Youth
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2016.0088
– volume: 301
  start-page: 111082
  year: 2020
  ident: ref_27
  article-title: Reduced striatal GABA in unmedicated children with ADHD at 7T
  publication-title: Psychiatry Res. Neuroimaging
  doi: 10.1016/j.pscychresns.2020.111082
– volume: 7
  start-page: 421
  year: 2008
  ident: ref_73
  article-title: EEG phenotypes predict treatment outcome to stimulants in children with ADHD
  publication-title: J. Integr. Neurosci.
  doi: 10.1142/S0219635208001897
– volume: 122
  start-page: 2427
  year: 2019
  ident: ref_62
  article-title: EEG power spectral slope differs by ADHD status and stimulant medication exposure in early childhood
  publication-title: J. Neurophysiol.
  doi: 10.1152/jn.00388.2019
– volume: 9
  start-page: 242
  year: 2015
  ident: ref_43
  article-title: Normal Neurochemistry in the Prefrontal and Cerebellar Brain of Adults with Attention-Deficit Hyperactivity Disorder
  publication-title: Front. Behav. Neurosci.
  doi: 10.3389/fnbeh.2015.00242
– volume: 70
  start-page: 185
  year: 2013
  ident: ref_80
  article-title: Meta-analysis of Functional Magnetic Resonance Imaging Studies of Inhibition and Attention in Attention-deficit/Hyperactivity Disorder
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2013.277
– volume: 62
  start-page: 896
  year: 2005
  ident: ref_11
  article-title: Instability of the DSM-IV Subtypes of ADHD From Preschool Through Elementary School
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archpsyc.62.8.896
– volume: 13
  start-page: 42
  year: 2019
  ident: ref_5
  article-title: A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD)
  publication-title: Front. Hum. Neurosci.
  doi: 10.3389/fnhum.2019.00042
SSID ssj0000800350
Score 2.3324525
Snippet Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that has become increasingly prevalent worldwide. Its core symptoms, including...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 91
SubjectTerms amphetamine
Amphetamines
Anatomy
Attention deficit hyperactivity disorder
Biomarkers
Brain research
Catecholamines
Children
Dopamine
Electrophysiology
executive function
Hyperactivity
inhibitory control
Life span
Magnetic resonance spectroscopy
methylphenidate
Neostriatum
Neurobiology
Neurodevelopmental disorders
norepinephrine
Precision medicine
Scalp
Teenagers
γ-Aminobutyric acid
SummonAdditionalLinks – databaseName: Biological Science Database
  dbid: M7P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5B4cClFMojUJCREBKHaO3YeXGpti8VCVZ7AKm3yE7G7UrgbXe3CP49Y8cb2Ar1wjG2E400Hs_3jSczAG_zwnCZG0yJdhFBKQpMtRE6lbW1WFQdeZRQZ_ZTOZlUZ2f1NAbcljGtcn0mhoO6m7c-Rj7KVEngu6IDd__yKvVdo_ztamyhcRfu-SoJWUjdmw4xFo-GZM7720lJ7H5kfN8F8i3k9AShC7HhjULR_n8hzZsJk395oJOH_yv7DmxH7MnG_WZ5BHfQPYbdsSPe_f0Xe8dCNmgIs-_CZLqI3XfY53j9zvy_Smzm2Pjo9OgDow1GI0tkBHuZr_FBnz7-2caa30y7jn10FzMTcsKewNeT4y-Hp2nsvZC2quarVBLQ0nWl2tbW3PJaZ5Zj3nWqUFagKa1voVhwJPrZIflZ4m0CqzrXmbK8akv5FLbc3OFzYEYT6-mEbglMKLT0qMrSICG_Vqu6wARGax00ayF9f4xvDREUr7XmptYSeD-8cdkX5bhl7YFX67DOl9MOA_PFeROts0FlhNJYlTozCkVuZIdV3vHMGoJL2iSwt1ZsE2182fzRagJvhmmyTn_loh3Or_s1RMiIIybwrN9DgyRSKkLHQiVQbuyuDVE3Z9zsIlQAJ1hHwI6_uF2sl_Ag8xk4XKRC7sHWanGNr-B--2M1Wy5eB1P5DS5MHwM
  priority: 102
  providerName: ProQuest
Title Precision Medicine Care in ADHD: The Case for Neural Excitation and Inhibition
URI https://www.ncbi.nlm.nih.gov/pubmed/33450814
https://www.proquest.com/docview/2478628036
https://www.proquest.com/docview/2478585666
https://pubmed.ncbi.nlm.nih.gov/PMC7828220
https://doaj.org/article/e4b14ae87a2b4e15b3de85d02fb015ab
Volume 11
WOSCitedRecordID wos000609838500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: Directory of Open Access Journals (DOAJ)
  customDbUrl:
  eissn: 2076-3425
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000800350
  issn: 2076-3425
  databaseCode: DOA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2076-3425
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000800350
  issn: 2076-3425
  databaseCode: M~E
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 2076-3425
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000800350
  issn: 2076-3425
  databaseCode: M7P
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2076-3425
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000800350
  issn: 2076-3425
  databaseCode: BENPR
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2076-3425
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000800350
  issn: 2076-3425
  databaseCode: PIMPY
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Research Library
  customDbUrl:
  eissn: 2076-3425
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000800350
  issn: 2076-3425
  databaseCode: M2O
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwED7B4IEXBIwfgVEZCSHxENWOnTjeW8c6bRItEQKpPEV2ctaKtgy1HYL_fuckrdoJwQsvkWI70eV8zn1ffLkDeJtmjsvUYUy0iwhKlmFsnbCxNN5jltfkUdo8sx_1dJrPZqbYKvUVYsK69MCd4oaonFAWc20Tp1CkTtaYpzVPvCNPZl14-3JttsjU9x4HyZR3-5KSeP3QhYoL5FXI3QnCFWLHD7Xp-v-EMW-HSm75npNH8LAHjWzUCfsY7mDzBPZHDRHmy9_sHWvDONvv4_swLRZ92Rw26ffNWfjJiM0bNjo-PT5kZBnUskRGeJWF5Bx06_Gvqk_WzWxTs7PmfO7aYK6n8PVk_OXDadwXTYgrZfgqloSQrMlVVXnDPTc28RzTulaZ8gKd9qH2YcaReGON5CCJcAnMTWoT5XleafkM9pqrBl8Ac5boSi1sRShAoadTpbVDgmyVVSbDCIZrFZZrIUNhi4uSmEVQenlb6RG831zxo8um8ZexR2FWNuNCHuy2gayj7K2j_Jd1RHCwntOyX5zLMlGaeFxOvjuCN5tuWlZhr8Q2eHXdjSEmReQuguedCWwkkVIRrBUqAr1jHDui7vY08_M2dTfhMUJk_OX_eLZX8CAJATZcxEIewN5qcY2v4X71czVfLgZwV8_yAdw7Gk-Lz4N2ddBxknwKR11QT3E2Kb7dAGsdGAk
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VFAkuvMrDUGCRAImDlV3v-oWEUCCtEjWJcihSOZlde0wjgV2SFOif4jcy6xekQr31wNHrtbX2fjvzfd7xDMBzPzBc-gZdkl0kUIIAXW2EdmWc5xhEGXmUKs_sJJzNoqOjeL4Fv9p_YWxYZWsTK0Odlan9Rt73VEjkOyKD-_bkm2urRtnd1baERg2LAzz7QZJt9WY8pPl94Xn7e4fvR25TVcBNVczXriQKoeNIpWke85zH2ss5-lmmApULNGFuiwMGHElYZUgehBSJwCj2tadyHqWhpPtegW1lwd6D7fl4Ov_YfdWx_Ev6vN4PlTLmfWMrPZA3IzcriM-IDf9XlQn4F7c9H6L5l8_bv_m_va1bcKNh12xQL4fbsIXFHdgZFHpdfj1jL1kV71ptJOzAbL5s6guxaRNgwOzfWGxRsMFwNHzNaAlRywoZEXtms5jQrfd-pk1Wc6aLjI2L44Wpot7uwodLebJ70CvKAh8AM5p0XSZ0SnRJYU6HKgwNErdNtYoDdKDfznnSDtJWAPmSkASzKEnOo8SBV90VJ3XakQv6vrMw6vrZhOFVQ7n8nDT2J0FlhNIYhdozCoVvZIaRn3EvN0QItXFgtwVS0lixVfIHRQ48606T_bGbSrrA8rTuQ5KTVLAD92vMdiORUhH_F8qBcAPNG0PdPFMsjqsc50RcibryhxcP6ylcGx1OJ8lkPDt4BNc9G2_EhSvkLvTWy1N8DFfT7-vFavmkWagMPl022n8DdB19Sw
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VLUJceJVHoICRAIlDtHbsvJAQWtiuumq72gNI5ZTayZiuBEnZ3QL9a_w6xnksbIV664FjHCdy4s8z3xdPZgCeh5HhMjTok-wigRJF6GsjtC9TazFKCvIodZ7Z_XgySQ4P0-kG_Or-hXFhlZ1NrA11UeXuG3k_UDGR74QMbt-2YRHT4ejtyTffVZByO61dOY0GInt49oPk2-LNeEhz_SIIRjsf3u_6bYUBP1cpX_qS6IROE5XnNuWWpzqwHMOiUJGyAk1sXaHAiCOJrALJm5A6EZikoQ6U5UkeS7rvFdgkSq6CHmxOxwfTT6svPI6LyZA3e6NSprxvXNUH8mzkcgVxG7HmC-uSAf_iuefDNf_yf6Ob__ObuwU3WtbNBs0yuQ0bWN6BrUGpl9XXM_aS1XGw9QbDFkym87buEDtoAw-Y-0uLzUo2GO4OXzNaWtSyQEaEn7nsJnTrnZ95m-2c6bJg4_J4ZupouLvw8VKe7B70yqrEB8CMJr1XCJ0TjVJo6VDFsUHivLlWaYQe9Lv5z7pBusogXzKSZg4x2XnEePBqdcVJk47kgr7vHKRW_Vwi8bqhmn_OWruUoTJCaUxiHRiFIjSywCQseGANEUVtPNjuQJW11m2R_UGUB89Wp8kuuc0mXWJ12vQhKUrq2IP7DX5XI5FSkS4QyoN4DdlrQ10_U86O69znRGiJ0vKHFw_rKVwjiGf748neI7geuDAkLnwht6G3nJ_iY7iaf1_OFvMn7ZplcHTZYP8NopaGCw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Precision+Medicine+Care+in+ADHD%3A+The+Case+for+Neural+Excitation+and+Inhibition&rft.jtitle=Brain+sciences&rft.au=Ping+C.+Mamiya&rft.au=Anne+B.+Arnett&rft.au=Mark+A.+Stein&rft.date=2021-01-13&rft.pub=MDPI+AG&rft.eissn=2076-3425&rft.volume=11&rft.issue=1&rft.spage=91&rft_id=info:doi/10.3390%2Fbrainsci11010091&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_e4b14ae87a2b4e15b3de85d02fb015ab
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2076-3425&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2076-3425&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2076-3425&client=summon